| Feb 10, 2026 |
Feb 20, 2026 |
Angotti Vincent J.
|
CEO |
Buy |
95.0
|
+92,626
|
19.11%
|
✗
|
$75.3K |
| Feb 12, 2026 |
Feb 20, 2026 |
Aslam Shakil
|
Chief Medical Officer |
Buy |
91.3
|
+35,000
|
72.65%
|
✗
|
$28.4K |
| Feb 10, 2026 |
Feb 20, 2026 |
Dasu Badri N
|
Chief Engineering Officer |
Buy |
91.3
|
+31,873
|
75.87%
|
✗
|
$25.9K |
| Feb 10, 2026 |
Feb 20, 2026 |
ASADORIAN RAFFI
|
CFO |
Buy |
91.3
|
+41,109
|
22.25%
|
✗
|
$33.4K |
| Oct 23, 2025 |
Oct 24, 2025 |
HOFFMAN STEPHEN J
|
Director |
Neutral |
90.0
|
+4,267
|
92.92%
|
✗
|
- |
| Oct 23, 2025 |
Oct 24, 2025 |
WAN MARK A
|
Director |
Neutral |
90.0
|
+4,267
|
92.92%
|
✗
|
- |
| Oct 23, 2025 |
Oct 24, 2025 |
Bozilenko Marina
|
Director |
Neutral |
90.0
|
+4,267
|
89.27%
|
✗
|
- |
| Oct 23, 2025 |
Oct 24, 2025 |
Broadfoot Jill Marie
|
Director |
Neutral |
90.0
|
+4,267
|
99.70%
|
✗
|
- |
| Oct 23, 2025 |
Oct 24, 2025 |
ADAMS ADRIAN
|
Director |
Neutral |
90.0
|
+4,267
|
31.98%
|
✗
|
- |
| Oct 23, 2025 |
Oct 24, 2025 |
JAIN ABHINAV
|
Director |
Neutral |
90.0
|
+4,267
|
140.13%
|
✗
|
- |
| Oct 15, 2025 |
Oct 16, 2025 |
Todisco Joseph
|
Director |
Neutral |
90.0
|
+6,397
|
100.00%
|
✗
|
- |
|
Oct 16, 2025 |
Todisco Joseph
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Sep 12, 2025 |
CorMedix Inc.
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 20, 2025 |
May 21, 2025 |
Aslam Shakil
|
Chief Medical Officer |
Sell |
47.5
|
-4,517
|
-8.57%
|
✗
|
$2.3K |
| Apr 2, 2025 |
Apr 3, 2025 |
Aslam Shakil
|
Chief Medical Officer |
Neutral |
90.0
|
+15,000
|
39.79%
|
✗
|
- |
| Apr 2, 2025 |
Apr 3, 2025 |
Dasu Badri N
|
Chief Engineering Officer |
Neutral |
90.0
|
+15,000
|
55.53%
|
✗
|
- |
| Apr 2, 2025 |
Apr 3, 2025 |
ASADORIAN RAFFI
|
CFO |
Neutral |
90.0
|
+15,000
|
46.56%
|
✗
|
- |
| Apr 2, 2025 |
Apr 3, 2025 |
Angotti Vincent J.
|
CEO |
Buy |
95.0
|
+274,310
|
45.40%
|
✗
|
$125K |
| Mar 31, 2025 |
Apr 2, 2025 |
Nantahala Capital Management, LLC
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 13, 2024 |
Feb 26, 2025 |
Aslam Shakil
|
Chief Medical Officer |
Buy |
90.0
|
+5,695
|
17.80%
|
✗
|
$6K |
| Feb 14, 2025 |
Feb 18, 2025 |
Dasu Badri N
|
Chief Engineering Officer |
Sell |
47.5
|
-2,644
|
-8.92%
|
✗
|
$1.8K |
| Feb 14, 2025 |
Feb 18, 2025 |
ASADORIAN RAFFI
|
CFO |
Sell |
47.5
|
-3,245
|
-9.15%
|
✗
|
$2.2K |
| Feb 14, 2025 |
Feb 18, 2025 |
Angotti Vincent J.
|
CEO |
Sell |
47.5
|
-10,575
|
-5.26%
|
✗
|
$7.1K |
| Feb 10, 2025 |
Feb 12, 2025 |
Dasu Badri N
|
Chief Engineering Officer |
Sell |
47.5
|
-1,759
|
-2.84%
|
✗
|
$1.1K |
| Feb 10, 2025 |
Feb 12, 2025 |
ASADORIAN RAFFI
|
CFO |
Sell |
47.5
|
-2,119
|
-5.64%
|
✗
|
$1.3K |
| Feb 10, 2025 |
Feb 12, 2025 |
Angotti Vincent J.
|
CEO |
Sell |
47.5
|
-7,032
|
-3.38%
|
✗
|
$4.4K |
| Dec 5, 2024 |
Dec 6, 2024 |
Angotti Vincent J.
|
CEO |
Buy |
77.5
|
+5,000
|
2.46%
|
✗
|
$3.2K |
| Dec 2, 2024 |
Dec 2, 2024 |
ASADORIAN RAFFI
|
CFO |
Sell |
45.0
|
-155
|
-0.41%
|
✗
|
$118.9 |
| Nov 27, 2024 |
Dec 2, 2024 |
Angotti Vincent J.
|
CEO |
Buy |
82.5
|
+5,000
|
2.52%
|
✗
|
$3.6K |
|
Oct 10, 2024 |
Aslam Shakil
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 30, 2024 |
Sep 3, 2024 |
Angotti Vincent J.
|
CEO |
Buy |
82.5
|
+7,260
|
3.80%
|
✗
|
$7.6K |
| Jun 24, 2024 |
Jun 24, 2024 |
Bozilenko Marina
|
Director |
Neutral |
90.0
|
+2,174
|
83.42%
|
✗
|
- |
| Jun 24, 2024 |
Jun 24, 2024 |
HOFFMAN STEPHEN J
|
Director |
Neutral |
90.0
|
+2,174
|
89.91%
|
✗
|
- |
| Jun 24, 2024 |
Jun 24, 2024 |
ADAMS ADRIAN
|
Director |
Neutral |
90.0
|
+2,174
|
19.47%
|
✗
|
- |
| Jun 24, 2024 |
Jun 24, 2024 |
Broadfoot Jill Marie
|
Director |
Neutral |
90.0
|
+2,174
|
103.23%
|
✗
|
- |
| Jun 24, 2024 |
Jun 24, 2024 |
JAIN ABHINAV
|
Director |
Neutral |
90.0
|
+2,174
|
249.60%
|
✗
|
- |
| Jun 24, 2024 |
Jun 24, 2024 |
WAN MARK A
|
Director |
Neutral |
90.0
|
+2,174
|
89.91%
|
✗
|
- |
| Jun 12, 2024 |
Jun 14, 2024 |
Angotti Vincent J.
|
CEO |
Buy |
85.0
|
+10,000
|
5.85%
|
✗
|
$9.9K |
| Mar 19, 2024 |
Mar 21, 2024 |
Nantahala Capital Management, LLC
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 15, 2024 |
Mar 15, 2024 |
Nantahala Capital Management, LLC
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 11, 2024 |
Mar 12, 2024 |
Angotti Vincent J.
|
CEO |
Neutral |
85.0
|
+9,000
|
5.56%
|
✗
|
- |
| Mar 3, 2024 |
Mar 4, 2024 |
Dasu Badri N
|
Chief Engineering Officer |
Sell |
47.5
|
-406
|
-1.28%
|
✗
|
$527.8 |
| Mar 3, 2024 |
Mar 4, 2024 |
Palmer Pamela P
|
Chief Medical Officer |
Sell |
50.0
|
-450
|
-0.76%
|
✗
|
$585 |
| Mar 3, 2024 |
Mar 4, 2024 |
ASADORIAN RAFFI
|
CFO |
Sell |
47.5
|
-558
|
-1.46%
|
✗
|
$725.4 |
| Mar 3, 2024 |
Mar 4, 2024 |
Angotti Vincent J.
|
CEO |
Sell |
50.0
|
-1,623
|
-0.99%
|
✗
|
$2.1K |
| Feb 14, 2024 |
Feb 27, 2024 |
Palmer Pamela P
|
Chief Medical Officer |
Neutral |
90.0
|
+18,000
|
50.93%
|
✗
|
- |
| Feb 14, 2024 |
Feb 27, 2024 |
Dasu Badri N
|
Chief Engineering Officer |
Neutral |
90.0
|
+14,667
|
85.51%
|
✗
|
- |
| Feb 14, 2024 |
Feb 27, 2024 |
ASADORIAN RAFFI
|
CFO |
Neutral |
90.0
|
+18,000
|
88.71%
|
✗
|
- |
| Feb 14, 2024 |
Feb 27, 2024 |
Angotti Vincent J.
|
CEO |
Neutral |
90.0
|
+58,667
|
61.91%
|
✗
|
- |
| Feb 10, 2024 |
Feb 13, 2024 |
Dasu Badri N
|
Chief Engineering Officer |
Sell |
47.5
|
-1,618
|
-8.62%
|
✗
|
$1.8K |
| Feb 10, 2024 |
Feb 13, 2024 |
Palmer Pamela P
|
Chief Medical Officer |
Sell |
47.5
|
-1,602
|
-4.34%
|
✗
|
$1.8K |
| Feb 10, 2024 |
Feb 13, 2024 |
ASADORIAN RAFFI
|
CFO |
Sell |
47.5
|
-1,790
|
-8.11%
|
✗
|
$2K |
| Feb 10, 2024 |
Feb 13, 2024 |
Angotti Vincent J.
|
CEO |
Sell |
47.5
|
-7,043
|
-6.92%
|
✗
|
$7.7K |
| Jan 22, 2024 |
Jan 24, 2024 |
Nantahala Capital Management, LLC
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 22, 2024 |
Jan 23, 2024 |
JAIN ABHINAV
|
Director |
Neutral |
90.0
|
+871
|
100.00%
|
✗
|
- |
|
Jan 23, 2024 |
JAIN ABHINAV
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 22, 2024 |
Nantahala Capital Management, LLC
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 13, 2023 |
Dec 14, 2023 |
Angotti Vincent J.
|
CEO |
Buy |
90.0
|
+10,000
|
10.89%
|
✗
|
$7.3K |
| Oct 10, 2023 |
Dec 13, 2023 |
HOFFMAN STEPHEN J
|
Director |
Neutral |
90.0
|
+581
|
31.63%
|
✗
|
- |
| Oct 10, 2023 |
Dec 13, 2023 |
Afable Richard
|
Director |
Neutral |
90.0
|
+581
|
30.79%
|
✗
|
- |
| Oct 10, 2023 |
Dec 13, 2023 |
WAN MARK A
|
Director |
Neutral |
90.0
|
+581
|
31.63%
|
✗
|
- |
| Oct 10, 2023 |
Dec 13, 2023 |
Bozilenko Marina
|
Director |
Neutral |
90.0
|
+581
|
28.69%
|
✗
|
- |
| Oct 10, 2023 |
Dec 13, 2023 |
Broadfoot Jill Marie
|
Director |
Neutral |
90.0
|
+581
|
38.10%
|
✗
|
- |
| Oct 10, 2023 |
Dec 13, 2023 |
Rosen Howard B
|
Director |
Neutral |
90.0
|
+581
|
12.33%
|
✗
|
- |
| Oct 10, 2023 |
Dec 13, 2023 |
ADAMS ADRIAN
|
Director |
Neutral |
85.0
|
+581
|
5.49%
|
✗
|
- |
| Sep 11, 2023 |
Sep 11, 2023 |
Angotti Vincent J.
|
CEO |
Buy |
90.0
|
+10,000
|
12.22%
|
✗
|
$8K |
| Aug 24, 2023 |
Aug 25, 2023 |
Palmer Pamela P
|
Chief Medical Officer |
Sell |
26.3
|
-16,956
|
-35.54%
|
✗
|
$19.2K |
| Mar 3, 2023 |
Mar 6, 2023 |
Dasu Badri N
|
Chief Engineering Officer |
Sell |
47.5
|
-398
|
-2.08%
|
✗
|
$521.4 |
| Mar 3, 2023 |
Mar 6, 2023 |
Palmer Pamela P
|
Chief Medical Officer |
Sell |
47.5
|
-570
|
-1.30%
|
✗
|
$746.7 |
| Mar 3, 2023 |
Mar 6, 2023 |
ASADORIAN RAFFI
|
CFO |
Sell |
47.5
|
-510
|
-2.26%
|
✗
|
$668.1 |
| Mar 3, 2023 |
Mar 6, 2023 |
Angotti Vincent J.
|
CEO |
Sell |
47.5
|
-1,703
|
-2.60%
|
✗
|
$2.2K |
| Feb 10, 2023 |
Feb 14, 2023 |
Palmer Pamela P
|
Chief Medical Officer |
Sell |
90.0
|
+5,108
|
13.17%
|
✗
|
$1.7K |
| Feb 10, 2023 |
Feb 14, 2023 |
Dasu Badri N
|
Chief Engineering Officer |
Sell |
90.0
|
+4,099
|
27.20%
|
✗
|
$1.3K |
| Feb 10, 2023 |
Feb 14, 2023 |
ASADORIAN RAFFI
|
CFO |
Sell |
90.0
|
+5,002
|
28.44%
|
✗
|
$1.5K |
| Feb 10, 2023 |
Feb 14, 2023 |
Angotti Vincent J.
|
CEO |
Sell |
90.0
|
+16,179
|
32.78%
|
✗
|
$5.6K |
| Feb 6, 2023 |
Feb 8, 2023 |
Dasu Badri N
|
Chief Engineering Officer |
Sell |
47.5
|
-458
|
-2.95%
|
✗
|
$925.2 |
| Feb 6, 2023 |
Feb 8, 2023 |
ASADORIAN RAFFI
|
CFO |
Sell |
47.5
|
-617
|
-3.39%
|
✗
|
$1.2K |
| Feb 6, 2023 |
Feb 8, 2023 |
Palmer Pamela P
|
Chief Medical Officer |
Sell |
47.5
|
-681
|
-1.73%
|
✗
|
$1.4K |
| Feb 6, 2023 |
Feb 8, 2023 |
Angotti Vincent J.
|
CEO |
Sell |
47.5
|
-1,982
|
-3.86%
|
✗
|
$4K |
| Jul 15, 2022 |
Jul 15, 2022 |
Broadfoot Jill Marie
|
Director |
Neutral |
90.0
|
+15,500
|
103.33%
|
✗
|
- |
| Jul 15, 2022 |
Jul 15, 2022 |
Bozilenko Marina
|
Director |
Neutral |
90.0
|
+15,500
|
62.00%
|
✗
|
- |
| Jul 15, 2022 |
Jul 15, 2022 |
Afable Richard
|
Director |
Neutral |
90.0
|
+15,500
|
69.66%
|
✗
|
- |
| Jul 15, 2022 |
Jul 15, 2022 |
ADAMS ADRIAN
|
Director |
Neutral |
85.0
|
+15,500
|
7.90%
|
✗
|
- |
| Jul 15, 2022 |
Jul 15, 2022 |
HOFFMAN STEPHEN J
|
Director |
Neutral |
90.0
|
+15,500
|
72.94%
|
✗
|
- |
| Jul 15, 2022 |
Jul 15, 2022 |
Rosen Howard B
|
Director |
Neutral |
90.0
|
+15,500
|
19.68%
|
✗
|
- |
| Jul 15, 2022 |
Jul 15, 2022 |
WAN MARK A
|
Director |
Neutral |
90.0
|
+15,500
|
72.94%
|
✗
|
- |
| Jun 7, 2022 |
Jun 8, 2022 |
Angotti Vincent J.
|
CEO |
Buy |
83.8
|
+46,400
|
4.78%
|
✗
|
$10.3K |
| Mar 3, 2022 |
Mar 4, 2022 |
Palmer Pamela P
|
Chief Medical Officer |
Sell |
47.5
|
-7,923
|
-1.01%
|
✗
|
$3.2K |
| Mar 3, 2022 |
Mar 4, 2022 |
Dasu Badri N
|
Chief Engineering Officer |
Sell |
47.5
|
-5,612
|
-1.83%
|
✗
|
$2.3K |
| Mar 3, 2022 |
Mar 4, 2022 |
ASADORIAN RAFFI
|
CFO |
Sell |
47.5
|
-7,923
|
-2.13%
|
✗
|
$3.2K |
| Mar 3, 2022 |
Mar 4, 2022 |
Angotti Vincent J.
|
CEO |
Sell |
47.5
|
-23,051
|
-2.32%
|
✗
|
$9.4K |
| Feb 11, 2022 |
Feb 14, 2022 |
Palmer Pamela P
|
Chief Medical Officer |
Sell |
90.0
|
+114,573
|
17.29%
|
✗
|
$3.2K |
| Feb 11, 2022 |
Feb 14, 2022 |
Dasu Badri N
|
Chief Engineering Officer |
Sell |
90.0
|
+91,885
|
44.97%
|
✗
|
$2.3K |
| Feb 11, 2022 |
Feb 14, 2022 |
ASADORIAN RAFFI
|
CFO |
Sell |
90.0
|
+109,573
|
17.27%
|
✗
|
$3.2K |
| Feb 11, 2022 |
Feb 14, 2022 |
Angotti Vincent J.
|
CEO |
Sell |
90.0
|
+366,942
|
59.51%
|
✗
|
$9.3K |
| Feb 6, 2022 |
Feb 7, 2022 |
Palmer Pamela P
|
Chief Medical Officer |
Sell |
47.5
|
-9,391
|
-1.40%
|
✗
|
$4K |
| Feb 6, 2022 |
Feb 7, 2022 |
Dasu Badri N
|
Chief Engineering Officer |
Sell |
47.5
|
-6,830
|
-3.23%
|
✗
|
$2.9K |
| Feb 6, 2022 |
Feb 7, 2022 |
ASADORIAN RAFFI
|
CFO |
Sell |
47.5
|
-9,391
|
-3.51%
|
✗
|
$4K |
| Feb 6, 2022 |
Feb 7, 2022 |
Angotti Vincent J.
|
CEO |
Sell |
46.3
|
-27,318
|
-4.24%
|
✗
|
$11.8K |
| Nov 20, 2021 |
Nov 23, 2021 |
Broadfoot Jill Marie
|
Director |
Neutral |
90.0
|
+15,000
|
100.00%
|
✗
|
- |